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Background: Telomeres are repeated DNA sequences at the end of chromosomes. Each cell 
division causes telomere shortening. Under normal circumstance, when telomeres are shortened 
to a critical level, the programmed cell death or apoptosis mechanism is invoked and results in 
cell death. However, some rare cells, even with extremely short telomeres, escape the apoptosis 
pathway with sustaining proliferation, a hall marker of cancer. Therefore, telomeres may play an 
important role in the development and progression of cancer. However, despite the public health 
significance of colorectal cancer, there is a lack of consensus about the association between 
telomere length and colorectal cancer.  
Objective: The present study was to prospectively examine the association between telomere 
length and the risk of developing colorectal cancer.  
Methods: We obtained blood sample from 26,761 cancer-free participants at baseline in 
Singapore Chinese Health Study between April 1994 and April 2005. Telomere length in 
leukocytes was quantified using monochrome qPCR. Until December 31, 2008, 347 subjects 
developed colorectal cancer (209 colon cancer and 138 rectal cancer). Multivariate Cox 
proportional hazard regression models were used to estimate hazard ratio (HR) and their 95% 
confidence interval (CI) of for risk of colon, rectal and colorectal cancer associated with longer 
telomeres compared with shorter telomeres after adjusting for multiple covariates. 
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Results: Subjects with highest quartile of telomere length had a statistically significant 55% 
increased risk of colorectal cancer (HR=1.55, 95% CI: 1.14-2.10) compared with the lowest 
quartile of telomere length after adjusting for potential confounders (p-trend=0.013). This 
positive association became stronger (HR=1.70, 95% CI: 1.16-2.48) after excluding patients who 
were diagnosed with colorectal cancer within the first two years post blood collection (p-
trend=0.022). A statistically significant and stronger association between telomere length and 
risk of colorectal cancer was observed among never smokers and participants without history of 
diabetes. 
Conclusion: This large cohort study built on Singapore Chinese population provides new 
evidence that longer telomere is associated with a higher risk of colorectal cancer, particularly 
among those who never smoked cigarettes or had no history of diabetes. Further studies are 
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1.0  INTRODUCTION 
1.1 TELOMERES 
Telomeres are repeated TTAGGG sequences at the end of eukaryotic chromosomes, 
coated by shelterin proteins (1). These proteins are involved in the process of telomere 
homeostasis to maintain chromosomal integrity and stability. Telomere repeat-binding factor 1 
(TRF1), one of the shelterin proteins, can be bound to long telomeres to prevent excessive 
lengthening of telomeres by regulating telomerase access and stabilize telomere (2). Telomerase 
is composed of human telomeric reverse transcriptase (h-TERT) and human telomeric RNA 
component (h-TERC). As the main positive regulator of telomere length, telomerase can use h-
TERC as a template and h-TERT as an enzyme to add telomeric repeats (3). In the process of 
cell division and aging, telomere length (TL) become shorter due to the end replication problem 
in most somatic cells that are lack of telomerase. The end replication problem is the shorten on 
the 5’ end of the new DNA due to the lack of RNA primer in each round of cell duplication. 
Longer TL indicates higher cell duplication capacity, and telomere length erosion, in turn, leads 
to cell senescence and aging. Thus, telomere shortening was thought to be an important tumor-
suppressive mechanism by trigging cell-cycle arrest to stop cell division (4). Many rare 
monogenic disorders indicate that both short and long telomere length are associated with 
cancers (5). However, the association between telomere length changes and sporadic cancers 
onset and progression among general population is still not well known. This association may be 
distorted by factors affecting telomere length, so it is critical to assess those factors. 
 
Age is the strongest predictor of TL. A longitudinal study conducted by Chen et al. 
indicated that age-dependent telomere attrition is the major pattern of telomere dynamics in 
peripheral blood leukocytes (6). There is also a consistent finding that males have significantly 
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shorter TL than females (6-8). Von Zglinicki reported that oxidative stress accelerates TL 
erosion (9). However, the findings on the relationship between TL and unhealthy life style, 
including smoking, obesity, alcohol intake and lack of exercise, which may cause oxidative 
stress are controversial. One longitudinal study measuring the TL at three-time points among 
4576 individuals reported no relationship between telomere attrition and unhealthy life style. In 
contrast, another longitudinal study conducted among 8074 participants at three-time points 
indicated that smoking accelerates telomere shortening (7, 8). To assess an unbiased relationship 
between telomere length and cancer, we may need to adjust for the above factors. 
1.2 EPIDEMIOLOGY OF COLORECTAL CANCER 
Colorectal cancer (CRC) is the second and third most common cancer among females 
and males worldwide (age-standardized incidence rates: 34.9 per 100,000 individuals) (10). CRC 
was also listed among the top 20 causes of death globally and this rank was predicted to increase 
with time (11). According to patients’ family history, colorectal cancer can be divided into 
sporadic and hereditary. Around three forth of cancer cases are sporadic, and the majority of 
them are in patients over 50 years old (10). Men have a higher risk of developing CRC than 
women in most parts of the world (12). Incidence of CRC varies by regions; more-developed 
countries have a higher morbidity than less-developed countries. In the United States, the 
average lifetime risk for colorectal cancer is 4.7% in females and 5.0% in males (13). Singapore 
is a multiethnic country, which consists of 75% Chinese, 13% Malays, 9% Indians and 3% 
others. Based on the Singapore Cancer Registry Annual Report 2015, colorectal cancer is the 
most common cancer in Singapore, and Chinese population had the highest risk (age-
standardized incidence rates: 41.7 per 100,000 individuals) of developing CRC compared with 
other ethical groups (14). More than 75% of CRC cases were diagnosed among individuals over 
55 years old. Consistent with the global epidemiologic trend, men in Singapore had substantially 
higher age-standardized incidence rates of CRC (14). In Singapore, the estimated lifetime 
probability of colorectal cancer is 2.9% for women and 3.9% for men (15).  
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The global burden of CRC emphasizes the importance of risk factors assessment. 
Known environmental risk factors included intake of red meat and processed meat, smoking, 
alcohol intake, low physical activity, obesity and type 2 diabetes. Studies about ethnic disparity 
in CRC incidence were mainly conducted in the United States (13, 16, 17). Researchers found 
substantially higher CRC rates among African Americans compared with other racial groups. 
The above studies concluded that low socioeconomic status, prevalence of obesity, diabetes, and 
less likely to undergo routine screening are responsible for the racial disparity, which indicates 
that there is no major difference in CRC risk caused by race itself. Further research about new 
risk factors will provide us new etiology and potentially new ways of prevention, diagnosis, 
prognosis or even treatment to the disease. 
 
Singapore has a higher incidence of CRC compared with the worldwide incidence, but a 
lower lifetime risk than the United States. Overall, the epidemiology of CRC in Singapore is 
close to the world level, and the high number of cases in Chinese population can enable the study 
with an appropriate sample size. More importantly, the Singapore Cancer Registry is one of the 
oldest and well-established registries in the world, and thus, using data from this registry system 
can reduce bias. Therefore, Singapore can act as a representative population to analyze risk 
factors of CRC.  
 
 As we all know, the endless division of cells is one of the hall markers of cancers, 
including colorectal cancer (18). The interaction between cell division and telomere length in 
non-cancer cells from general population can be concluded that: 1) Cells with longer telomere 
length have stronger potential of duplication compared with shorter telomeres, and, 2) 
Programmed cell death or apoptosis mechanism is invoked and leads to cell death, when 
telomeric structure is lost to a critical level during somatic cell division, and, 3) telomere 
shortening was thought to be an important tumor-suppressive mechanism by trigging cell-cycle 
arrest to stop cell duplication. With that being the case, extremely long TL is likely to promote 
cell replication and result in cancerous. Therefore, the patterns of telomere length regulation 
might be an important mechanism and potential risk factor for cancers. Several studies 
consistently reported on the level of TRF1 protein and Telomerase activity in tumor tissue during 
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CRC progression (19-23). However, the association between TL in leukocytes and CRC is still 
ambiguous.  
1.3 PREVIOUS EPIDEMIOLOGICAL STUDIES 
   We performed a literature search to review all published papers about the relationship 
between TL and CRC, and summarized them in Supplemental Table 1. Telomere lengths were 
shorter in cancer tissue than in adjacent mucosa, regardless of cancer stage, site and genetic 
alternation (24) (25). Telomere lengths among different normal tissues including skin, blood, 
synovium and colon mucosa were significantly positively associated with each other and they 
performed similar telomere shortening patterns with age in non-cancer individuals (26, 27). 
However, this common pattern of change in TL is lost among normal colon mucosa, tumor tissue 
and peripheral blood leukocytes (PBL) in CRC patients (27). In this case, the association 
between TL from blood cells and CRC may be affected by cancer.  
 
There is a lack of consensus about the relationship between CRC and TL from PBL in 
retrospective studies. One study based on a Chinese population reported that shorter TL was 
associated with CRC after adjusting for age, sex, smoking status and alcohol use (28). Pellatt et 
al. observed shorter TL among colon cancer patients after adjusting for age and sex. However, 
this association was attenuated in further adjustment for BMI and smoking (29). Boardman el al. 
analyzed 598 cases and 2212 healthy controls. They found younger individuals (<50 years old) 
with longer TL or older individuals (>50 years old) with shorter TL were under higher risk of 
CRC after adjusting for diet, alcohol, tobacco, hormone therapy (among females only), diabetes, 
family history of CRC, age at blood draw, BMI and medicine use (30). The above case-control 
studies recruited participants without history of receiving chemotherapy or radiotherapy. One 
study concluded that the association between shorter TL and CRC risk in retrospective studies 
becomes weaker in prospective studies, which indicated that CRC occurrence affected telomere 
length in PBL (31). Therefore, prospective study designs are superior to retrospective study 
designs to investigate changes in TL before cancer onset. 
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Lack of consensus also exists among four prospective studies. All published prospective 
studies used a nested case control design. Two studies were conducted on White females and 
males separately. Conditional on age, smoking, BMI, alcohol use, exercise and length of follow 
up, no evidence of association between TL and risk of CRC was found in both genders (32) (33). 
The other two studies were conducted among Chinese. The Shanghai women’s health study 
reported a higher CRC risk among individuals with longer and shorter TL after adjusting for age, 
date and time of sample collection, menopausal status, antibiotic use in past week and time 
interval since last meal (34). Zhang et al. detected an association between shorter TL and CRC 
risk adjusting for age, sex, smoking status and alcohol use (35). Naing el al. conducted a meta-
analysis using the above mentioned seven studies (28-34) in order to measure the relationship 
between TL in PBL and CRC risk (36). This meta-analysis found no evidence on the association 
based on a pooled analysis.  
 
It is possible that TL shortening usually occurs after cancer diagnosis, based on the above 
cross-sectional and retrospective studies. However, the prospective studies on the change of TL 
prior to CRC onset are still limited according to the inconsistent findings from the above 
prospective studies. Thus, the primary aim of this study is to prospectively assess the role of TL 
in the risk of CRC, and we hypothesize that longer TL is associated with a higher risk of CRC. In 
addition, this study will hopefully shed some light on the role of telomere length as a marker of 
cancer progression by clearing the TL dynamic patterns in different stages of colorectal cancer.  
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2.0  MATERIALS AND METHODS 
2.1 STUDY POPULATION 
A residential cohort of 63257 middle-aged and older (45-74 years) Singapore Chinese 
men and women was assembled between 1993 and 1998. At recruitment, each study subject was 
interviewed in person by a trained interviewer using a structured questionnaire that asked for 
information on demographics, body weight and height, lifetime use of tobacco (cigarettes and 
water-pipe), current physical activity, menstrual/reproductive history (women only), 
occupational exposure, medical history, and family history of cancer. Body mass index (BMI) 
was calculated as the current weight in kilograms divided by height in meters squared. 
Information on current diet and consumption of beverage was assessed via a 165-item food 
frequency questionnaire that had been violated against a series of 24-hour dietary interview (37).  
 
Beginning in April 1994, a random 3% of cohort participants were asked to provide 
blood. Eligibility for this biospecimen subcohort was extended to all surviving cohort 
participants starting in January 2000. By April 2005, all surviving cohort participants had been 
contacted for biospecimen donation. 28,346 subjects donated baseline blood samples, 
representing a consent rate of about 60%. Between July 1999 and December 2003, all surviving 
cohort subjects were recontacted for a telephone interview to update information on alcohol use, 
tobacco use, diabetes states, current physical activity, and body weight. 
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2.2 ASSESSMENT OF COLORECTAL CANCER CASES 
Identification of incident colorectal cancer cases and deaths (International Classification 
of Disease-Oncology codes, 2nd edition-ICD-O2) was accomplished by annual record linkage of 
all surviving cohort participants with the database of the nationwide Singapore Cancer Registry 
(38) and the Birth and Death Registry that have complete records of incident cancer and death 
cases, respectively. The ascertainment of cancer and death incidences among all study 
participants was virtually complete as to date, only 56 (<0.1%) of entire cohort participants were 
known to be lost to follow-up due to migration out of Singapore. 
 
By December 31, 2008, 314 developed colorectal cancer among 26,540 subjects after 
excluding 1,585 participants with a history of cancer at the time of blood collection and 221 
subjects without valid genomic DNA results, with a median follow-up of 6.36 years after their 
donation of blood sample, ranging from 2 days to 14.52 years.  
2.3 MEASUREMENT OF LEUKOCYTE TELOMERE LENGTH 
Genomic DNA was extracted from peripheral blood using QIAamp 96 DNA Blood kits 
(Qiagen, Valencia, CA) according to the manufacturer’s protocol. Telomere length was 
measured using a validated monochrome multiplex qPCR method, as described elsewhere (39). 
Briefly, this method measures the relative average telomere length in genomic DNA by 
determining the ratio of telomere repeated copy number (T) to single (albumin) gene copy 
number (S) in experimental samples relative to a reference sample. The DNA sample for the 
standard curve was composed of an equimolar pool of 77 samples selected from participants of 
the Singapore Chinese Health Study who were identified in a prior study; the telomere length 
values of all the 77 samples were within 10% of the population mean. This pooled DNA sample 
was run on all qPCR plates: 8 replicates for each of four concentrations (4, 0.9, 0.16 and 0.032 
ng/µl). Thermal cycling was carried out on an Applied Biosystem 7900 HT instrument, using 
PCR cycling conditions as described (39). Real-time PCR cycle thresholds, determined 
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independently for albumin gene (ALB) and telomere (TEL) amplification traces for all wells 
(experimental and standard DNA samples), were used to calculate telomere length with the 384-
well plate-based normalization of telomere length, which was more robust than the overall 
standard-curve based normalization. All experimental DNA samples were assayed in duplicate, 
and the average value of the two replicates was used for final analysis for each subject. The mean 
coefficient of variation, as a measure of reproducibility, of all technical sample duplicates for 
telomere length in the present study was 3.5%. 
2.4 STATISTICAL ANALYSIS 
Chi square test and t-test (for non-normally distributed variables, we used non-parametric 
test) were used to compare the distribution of selected variables between cancer cases and non-
cases. The analysis of covariance (ANCOVA) method was used to assess the difference in 
geometric mean 95% confidence intervals (CI) of telomere length by selected characteristics.  
 
For each participant, person-years at risk was computed from the date of blood draw to 
the date of colorectal cancer diagnosis, death, migration out of Singapore, or December 31, 2015. 
We initially stratified age into 8 groups (46-50, 51-55, 56-60, 61-65, 66-70, 71-75, 76-80 and 81-
86) to examine the association between age and cancer. Due to small number of cases in the 
younger age groups, the first four groups were combined and resulted in the following age 
groups: 46-65, 66-70, 71-75, 75-80 and 81-86 years. Participants were categorized into following 
body mass index (BMI) groups: underweight (BMI<18.5), normal weight (18.5≤ BMI<23.0), 
overweight (23.0≤BMI<27.0) and obese (BMI≥27), according to specific BMI cutoff for Asians 
(40). A new variable-smoking index was created to define participants as: never smokers, light 
smokers, whose onset smoking age ≥15 years old and cigarettes per day <13, and heavy smokers, 
whose onset smoking age ≥15 years old and cigarettes per day >13. We categorized telomere 
length by dividing it into quartiles: Q1 (relative length: 0.19-0.87), Q2 (relative length: 0.87-
1.00), Q3 (relative length: 1.00-1.15), and Q4 (relative length: 1.15-3.24).  
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Multivariate Cox proportional hazard regression models were used to calculate hazard 
ratio (HR) and the 95% CI of colon, rectal and colorectal cancer. To assess the potential 
interaction effect of risk factors on the association between TL and hazard of colorectal cancer, 
we calculated the HR of colon, rectal and colorectal cancer stratified by sex, smoking index, and 
diabetes status. We subtracted 2 years from the original years of follow-up to conduct sensitivity 
analysis. 
 
Statistical analyses were carried out by using SAS software 9.4. All P-values are two 
sided, and those that were less than 0.05 were considered being statistically significant. 
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3.0  RESULTS 
3.1 COHORT CHARACTERISTICS AND THE CHOICE OF CONFOUNDING 
FACTORS 
The distribution of baseline characteristics of cancer cases and non-cancer cases is shown 
in Table 1. There were significant associations between colorectal cancer and older age 
(p<0.0001), male gender (p<0.0001), lower education levels (p=0.0136), former and current 
smoking status (p<0.0001), heavy smoking (p<0.0001), longer years of smoking (p=0.0049), 
higher alcohol intake per day (p=0.0097) as well as diabetes (p=0.0004). Since age and gender 
are the two major factors associated with TL erosion, we assessed the relationship between TL 
with demographics and lifestyle factors conditional on age and sex. The geometric mean of 
telomere length was inversely associated with age at sample collection (p-trend<0.0001), male 
gender (p-trend<0.0001), and higher education levels (p-trend=0.0130). Subjects with diabetes 
(p=0.0139) and family history of colorectal cancer (p-trend=0.0381) had a longer geometric 
mean of TL compared with their counterparts (Table 2).  
 
In a multivariate Cos regression model (Supplemental Table 2), the hazard ratio of 
colorectal cancer was significantly associated with age (p-trend<0.0001), sex (p-trend<0.0001), 
and diabetes (p-trend=0.0049). The number of years of smoking was only significantly 
associated with rectal cancer (p-trend=0.0423).  
 
Based on the above results, we included the following covariates into fully adjusted 
models to assess the association between TL and risk of colorectal cancer: age, gender, BMI 
levels (<18.5, 18.5-<23.0, 23.0-<27.0, ≥27.0), education levels (no formal education, primary, 
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secondary, and above), smoking index (never smokers, light smokers, and heavy smokers), 
numbers of alcohol drinks per week (non-drinkers, <7 drinks/week, and ≥7 drinks/week), weekly 
physical activity, family history of CRC, and diabetic status. 
 
3.2 TELOMERE LENGTH AND COLORECTAL CANCER RISK 
There was a significant (p-trend=0.0129) association between colorectal cancer and TL in 
quartile after adjusted for all potential confounders described above (Table 3); participants with 
the longest telomere length in quartile had a higher risk of developing colorectal cancer 
(HR=1.55, 95% CI: 1.14-2.10) compared with those in the lowest quartile of TL. The 
associations for TL with risks of colon and rectal cancer were similar (Table 3). The positive 
association was present for TL with both colon and rectal cancer, although their trends tests did 
not reach statistical significant level due to relatively small sample size for each subsite of 
cancer. 
 
Given that the underlying disease progression might have impact on TL, we conducted 
sensitivity analysis after excluding patients who were diagnosed with colorectal cancer within 
the first two years post enrollment. The positive association was present for TL with risk of 
colorectal cancer (p-trend=0.0220), and colon or rectal cancer individually (Table 4). 
 
The hazard ratio of colorectal cancer by TL in quartile stratified by risk factors are shown 
in Table 5. The longest TL in quartile was associated with a higher risk of colorectal cancer 
among never smokers (HR=1.68, 95% CI: 1.110-2.527, p-trend=0.0148) and subjects with no 
history of diabetes (HR=1.68, 95% CI: 1.204-2.331, p-trend=0.0052). Similar associations were 
present between TL and risk of colon or rectal cancer individually among never smokers or 
participants without history of diabetes, the tests for trend did not reach statistical significance 
level. The associations between TL and colorectal cancer among diabetics or ever smokers. We 
examined potential interaction effect of these variables on colorectal cancer risk, but did not find 
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any significant effect of history of diabetes or smoking with TL on risk of colorectal cancer (both 
p’s for interaction >0.325).  
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4.0  DISCUSSION 
4.1 INTERPRETATION OF CONFOUNDING FACTORS 
Similar to previous studies (6-8), we observed that a shorter TL is associated with 
advanced age and male gender. A higher education level in this population may be a 
representation of other upstream unmeasured factors such as stress, social economic level and 
diet to name a few. These factors may participate in the process of accelerating TL shortening 
(41, 42). The longer telomere length observed among participants with diabetes and family 
history of CRC may be results of selection bias, that more healthier diabetic patients or subjects 
with family history of CRC were recruited to the study compared with their inpatient or dead 
companion, and the healthier individuals may have longer TL. However, we cannot deny the 
probability that this phenomenon is true.  
 
In the fully adjusted model, we observed older age, male gender and diabetes history to 
be independent risk factors for the development of colorectal cancer. Interestingly, longer years 
of smoking was only associated with rectal cancer. Aging is one of the main risk factors of CRC. 
There are a few mechanisms possibly underlying the link between aging and cancer development 
(43) : 1) Age-related proliferation of opportunistic bacteria destroying the function and 
composition of gut microbiome, and 2) Aging-related chronic inflammation in luminal 
environment. Overall, we found a significant association between male gender and a higher CRC 
risk in this population. Male gender is a risk factor for many chronic diseases, which may be 
caused by sex-specific exposure to risk factors and a protective effect of sex hormone (17). 
However, sex disparities in CRC are complicated. Males and females have different risks for 
different sites of cancer occurrence and women had worse prognosis compared with age-matched 
men due to gender-specific differences in cancer screening (44).  
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A meta-analysis which combined data from case-control and cohort studies reported an 
increasing colorectal cancer risk among diabetic patients (45). Our study also observed that 
diabetes was an independent risk factor for colon and rectal cancer. Hyperinsulinemia was 
proposed to be one of the explanations for a higher CRC risk in diabetes patients (46). Insulin 
has growth-promoting function, which may facilitate the growth of cancer cells. Unhealthy 
dietary habits leading to diabetes may also be responsible for the development of colorectal 
cancer. 
 
Our study found a significant p-trend value between longer years of smoking and rectal 
cancer in the fully adjusted model, which is consistent with two previously published studies 
among men (47, 48) . Both studies indicated that smoking was associated with rectal cancer. 
Two prospective studies in men and women reported a significant association between more than 
35 years of smoking and CRC risk (49, 50) . However, based on our data, the HR of rectal cancer 
among subjects smoking over 40 years was 1.590 and the 95% CI included zero. Our cohort 
study had smaller total sample size, number of cases and fewer smokers compared with the two 
prospective studies, which may explain our results. All previous research indicates that years of 
smoking is a more important indicator of cancer risk rather than a smoking status.  
 
Based on the above results, we can conclude that age, gender, smoking and diabetes acted 
as strong confounding factors between the association of telomere length with colorectal cancer. 
In contrast, alcohol intake, weekly physical activity, education levels, family history of CRC, and 
BMI were not associated with CRC and TL in this data set, indicating that there may be a 
complicated pathway among the above variables. Therefore, it is important to take all potential 
confounding factors into consideration.  
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4.2 RESULTS AND INTERPRETATION 
In the present study, we found subjects with the longest TL in quartile had a higher risk 
of developing CRC in the fully adjusted model. This association became stronger after inhibiting 
the effect of CRC on TL. The stratification analyses results indicate that the prediction role of 
longer TL in CRC incidence was stronger among the low risk participants who never smokers or 
without a history of diabetes. One possible reason might be the bigger sample size and more 
cases among never smokers and participants without diabetes. In addition, among diabetic 
patients and smokers, diabetic status and smoking may play more important roles in the process 
of cancer development compared with the effect of longer TL, which could be another 
explanation for our observations. 
 
Some studies show that the expression levels of telomeric proteins are altered in tumors 
and cancer cells. Some low grade gastrointestinal tumors expressed more TRF1 protein (51). 
Increased telomerase activity (TA) associates with the histological grade and staging of CRC 
(52). Many studies investigated the association between TL with TA and their prognosis role in 
CRC patients not receiving chemotherapy or radiation therapy (19-22). They consistently 
reported: 1) The shorter TL in early-stage tumor mucosa and a longer TL in advanced cancer 
mucosa, and, 2) Longer TL and positive TA in tumor mucosa is associated with the worse 
prognosis among CRC patients. Overall, tumor samples showed higher TA and higher TRF1 
protein levels compared with adjacent normal mucosa (23). Based on the above results, we can 
hypothesize that tumors in the early stage have higher division capacity and relatively less 
telomerase, so the speed of replacing lost telomeric repeats during division cannot catch up with 
the speed of cell duplication. Therefore, the previous studies observed shorter TL in tumor tissue 
compared with adjacent mucosa. The second hypothesis is that increased TA with cancer 
progress leads to a longer TL in higher stage colorectal cancer. In this case, longer TL observed 
in more advanced stage of CRC can predict a worse prognosis.  
 
This TL dynamic pattern before cancer onset and during cancer progression may 
partially explain the lack of consensus among published papers, even though telomere dynamics 
are different in PBL and tumor mucosa after cancer onset. Different patterns of association 
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between TL and CRC may be caused by the timing of cancer diagnosis in both (and mainly in) 
retrospective and prospective studies. In prospective studies, the appropriate length of follow-up 
time and reducing the effect of cancer on TL are two critical factors affecting the assessment of 
association between TL and CRC incidence. Besides, there are differences in confounding 
adjustment in the four prospective studies. Some of the previous studies did not adjust for 
important confounding factors such as diabetes, smoking, and physical activities. This may 
distort the true association between TL and CRC risk. 
 
4.3 PUBLIC HEALTH IMPORTANCE 
Based on the two-stage model of carcinogenesis, Aviv et al. proposed a hypothesis about 
the role of longer telomeres in development of cancers (53).We would like to use this hypothesis 
to explain the causal link between TL and CRC. The first stage is the occurrence of single or 
multiple mutations during stem cells’ replication in colon or rectum, which results mutated 
clones with higher capacity of duplication than adjacent cells. This telomere independent stage 
may happen in every individual, and the mutations accumulate with age. Individuals with longer 
telomeres possess stronger potential of cell division, so the mutated clones have higher chance to 
expand and undergo malignance transformation among subjects with longer TL during the 
second stage. Since telomere lengths were positively associated among different normal tissues 
before cancer onset (26, 27), the longer TL in PBL reflects a longer TL in colonic tissue cells. 
Therefore, longer TL is associated with a higher risk of developing CRC. Based on our findings 
and the hypotheses built on the previous paper about the change of TA, TRF1 and TL, we may 
use the combination of changes in expression of TRF1 protein and TA, as well as the TL 
dynamic patterns as a marker of CRC progression. Individuals with longer TL have a higher 
chance of developing CRC. Tumor tissue expresses more TRF1 and TA compared with adjacent 
mucosa. We will observe a shorter TL because of higher levels of TRF1 expression in the early 
cancer stage and telomere elongation with the increase of TA during cancer progression. 
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Our study also emphasizes the importance of smoking cessation and diabetes in CRC 
prevention. Our finding that longer years of smoking is a more significant risk factor for rectal 
cancer than smoking status should be used for strategies to encourage smokers to quit smoking 
early on rather than give up trying. Healthy dietary habits and life style actually can also reduce a 
proportion of new cases of CRC among smokers and diabetes patients, because some of them do 
not have genetic susceptibility for a longer telomere.  
 
4.4 STRENGTH AND LIMITATION 
Our data is derived from a cohort study with a big sample size and long-term follow-up. 
In the fully adjustment model, we controlled for many common causes of telomere length 
dynamic and colorectal cancer and tried to meet the condition of exchangeability between cancer 
cases and non-cases. These are the two major advantages of our analysis compared with the four 
other prospective studies. However, telomere length is not consistent during the life span of 
humans. It will change because of cell duplication in every individual. In this case, using the 
measurement of telomere length at one time point to describe the association between TL and 
cancer seems not convincing. As previously mentioned, Chen et al. (6) and Huzen et al. (7) 
reported a similar pattern of leukocytes telomere length (LTL) dynamic that is age-dependent 
telomere shortening. LTL elongation with age is unlikely to happen, which may be a result of 
measurement error (6). Therefore, we believe that the observed relationship between TL and 
CRC is not spurious given that we used reliable TL measurement procedures.  
 
This study has a few limitations. First of all, more cases are needed to increase the power 
of our study. Secondly, the dynamic of TL indicates that longitudinal study design with multiple 
measurements of TL over time would be a better choice to fully examine the association between 
TL and CRC. Third, our cohort population had the oldest mean age of blood extraction compared 
with other published prospective papers. Even though all studies adjusted for age, there may be 
unknown downstream confounding factors of age distorting the association between TL and 
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CRC. Lastly, the Singapore Chinese Health Study is based on a Chinese population, so our result 
may lack of external validity to different ethnic groups due to unknown racial/ethical differences. 
As an observational study, this research project still had many unmeasured confounding factors 
which may distort our interpretation of the relationship between TL and CRC incidence. 
 
In conclusion, we observed that longest telomere length in peripheral blood leukocytes is 
associated with higher risk of colorectal cancer in the Singapore Chinese Health Study cohort. 
The increasing trend of developing CRC among longer TL participants is more significant 





Table 1. Characteristics of colorectal cancer cases and non-cases: The Singapore Chinese Health Study 1993-2008 
Characteristics Cancer cases Non-cases P-value 
Number of subjects 347 26193  











Mean BMI (SD), kg/m2 23.05 (3.44) 23.26 (3.51) 0.2725 
Level of education, % 
No formal education 
Primary (1-6 years) 







45.28   
33.94 
0.0136 













Median cigarettes/day (25%, 75%)* 15 (8, 20) 15 (9, 20) 0.7213 
Median years of smoking (25%, 75%)* 38 (28, 48) 36 (25, 44) 0.0049 
Median pack-years of smoking (25%, 75%)* 25 (12, 43) 24 (10.5, 42) 0.4010 
No. of alcohol drinks per week, % 
Non-drinkers 
<7 drinks/week 










Median alcohol intake (g) per day (25%, 75%)* 5.76 (1.92, 13.50) 3.85 (0.90, 10.33) 0.0097 






























* Only among smokers and alcohol drinkers 
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Table 2. Distribution of telomere length by selected demographics factors of study participants: The Singapore Chinese Health Study 
1993-2008 
 




















1.131 (1.105, 1.158) 
1.061 (1.055, 1.067) 
1.034 (1.029, 1.0410) 
0.992 (0.987, 0.997) 
0.959 (0.952, 0.965) 
0.925 (0.918, 0.932) 
0.900 (0.891, 0.910) 










1.017 (1.013, 1.020) 














0.988 (0.978, 0.997) 
0.995 (0.992, 0.999) 
0.996 (0.992, 1.001) 
0.995 (0.988, 1.002) 
 
0.3713 
Levels of education 
No formal education 
Primary (1-6 years) 






1.001 (0.995, 1.008) 
0.995 (0.992, 0.999) 
0.991 (0.987, 0.996) 
 
0.0130 









0.996 (0.992, 0.999) 
0.999 (0.990, 1.007) 













0.994 (0.992, 0.997) 
1.003 (0.996, 1.010) 
0.985 (0.973, 0.997) 
 
0.8229 







0.995 (0.992, 0.998) 
0.996 (0.991, 0.999) 
 
0.8580 







0.995 (0.992, 0.997) 










0.994 (0.992, 0.997) 
1.006 (0.997, 1.016) 
 
0.0139 
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Table 3. Hazard ratio of colorectal cancer by telomere length in quartile: The Singapore Chinese Health Study 1993-2008 
 
Relative telomere 






Colon cancer Rectal cancer 
Cancer 
cases 
HR (95% CI)* Cancer 
cases 
HR (95% CI)* Cancer 
cases 



















1.257 (0.938, 1.684) 
1.179 (0.865, 1.607) 









1.081 (0.742, 1.575) 
1.082 (0.730, 1.603) 









1.594 (0.997, 2.549) 
1.365 (0.824, 2.262) 
1.742 (1.054, 2.878) 
0.0649 
*Adjusted for:  age, gender, BMI levels (<18.5, 18.5-<23.0, 23.0-<27.0, ≥27.0), education levels (no formal education, primary, secondary, and 
above), smoking index (never smokers, light smokers, and heavy smokers), numbers of alcohol drinks per week (non-drinkers, <7 drinks/week, 




















Table 4. Hazard ratio of colorectal Cancer by telomere length in quartile after excluding cases in the first two years: The Singapore 










Colon cancer Rectal cancer 
Cancer 
cases 
HR (95% CI)* Cancer 
cases 
HR (95% CI)* Cancer 
cases 



















1.454 (1.014, 2.085) 
1.186 (0.801, 1.756) 









1.310 (0.823, 2.087) 
1.194 (0.728, 1.958) 









1.702 (0.960, 3.019) 
1.175 (0.616, 2.240) 
2.004 (1.103, 3.642) 
0.0745 
*Adjusted for:  age, gender, BMI levels (<18.5, 18.5-<23.0, 23.0-<27.0, ≥27.0), education levels (no formal education, primary, secondary, and 
above), smoking index (never smokers, light smokers, and heavy smokers), numbers of alcohol drinks per week (non-drinkers, <7 drinks/week, 




















Table 5. Hazard ratio of colorectal cancer by telomere length in quartile stratified by selected characteristics: The Singapore Chinese 
Health Study 1993-2008 
 




Colorectal cancer Colon cancer Rectal cancer 
Cancer 
cases 



























1.141 (0.691, 1.882) 
1.315 (0.804, 2.151) 










0.957 (0.525, 1.743) 
1.031 (0.567, 1.877) 










1.724 (0.677, 4.391) 
2.212 (0.894, 5.476) 




















1.327 (0.925, 1.902) 
1.069 (0.713, 1.604) 










1.166 (0.719, 1.891) 
1.097 (0.650, 1.852) 










1.574 (0.913, 2.714) 
1.037 (0.546, 1.969) 
1.469 (0.787, 2.742) 
 
0.4548 

















1.185 (0.782, 1.796) 
1.265 (0.831, 1.925) 










1.030 (0.619, 1.713) 
1.189 (0.717, 1.972) 










1.593 (0.765, 3.317) 
1.473 (0.690, 3.144) 




















1.364 (0.904, 2.059) 
1.083 (0.680, 1.724) 










1.178 (0.673, 2.062) 
0.937 (0.495, 1.772) 










1.650 (0.895, 3.042) 
1.303 (0.657, 2.587) 
1.354 (0.654, 2.804) 
 
0.5079 

















1.324 (0.966, 1.815) 
1.267 (0.907, 1.768) 










1.088 (0.725, 1.632) 
1.135 (0.745, 1.727) 










1.807 (1.085, 3.012) 
1.540 (0.887, 2.675) 
1.963 (1.131, 3.407) 
 
0.0367 

















0.797 (0.360, 1.765) 
0.702 (0.300, 1.643) 










0.924 (0.333, 2.562) 
0.720 (0.230,2.249) 










0.651 (0.181, 2.347) 
0.676 (0.187, 2.438) 
0.947 (0.281, 3.197) 
 
0.9512 
*Adjusted for:  age, gender, BMI levels (<18.5, 18.5-<23.0, 23.0-<27.0, ≥27.0), education levels (no formal education, primary, secondary, and above), smoking 
index (never smokers, light smokers, and heavy smokers), numbers of alcohol drinks per week (non-drinkers, <7 drinks/week, and ≥7 drinks/week), weekly 
physical activity, family history of CRC, and diabetic status. 
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Supplemental Table 1. Summary of results from previous epidemiological studies on telomere length and risk of colorectal cancer up to November 2017 
















PCR Telomeres were shorter in CRCs than in adjacent tissues, regardless of 
tumor stage and grade, site, or genetic alternations.  
(24) 









Telomeres were significantly shorter in CRCs than in adjacent tissues, 
regardless of tumor stage and grade, site, or genetic alternations. 
(25) 
Case-control 628 newly diagnosed 
CRC cases/ 1256 age 




Shorter telomere was significantly associated with CRC risk. 
Adjusted for:  age, sex, smoking status and alcohol use. 
(28) 
Case-control 249 colon cancer 
cases/ 371 controls; 
276 rectal cancer 
cases/ 372 controls 
PBL* qPCR Longer TL was significantly associated with reduced colon cancer risk 
after adjusting for age and sex. This significant association attenuated 
in further adjustment for BMI and smoking. 
 
(29) 
Case-control 598/2212 PBL* qPCR Younger (<50) individuals with longer TL or older (>50) individuals 
with shorter TL at higher risk for CRC.  
Adjusted for: fruit, vegetable, and red meat consumption, alcohol, 
tobacco and hormone therapy, diabetes, family history of CRC, age at 





134/357 matched  
White females 
(1993-Dec. 2005) 
PBL* qPCR No evidence for an association of loge-TSRs with CRC risk.  
Adjusted by BMI, randomized treatment group, presence of colorectal 






191/ 306 matched  
White males 
(1982-Dec. 2005) 
PBL* qPCR No evidence for an association of the observed T/S ratio with CRC risk.  












Ended in Dec. 2009) 
PBL* qPCR A U-shaped association: the lowest risk was observed in women with 
TSR in the third quintile, and risks were elevated with a shorter or 
longer TL.  
Adjusted by matched sets: age, date and time of sample collection, 





300 cases/ 900 
controls 
(June 2010-Jan 2015) 
PBL* Real Time 
PCR 
Shorter TL was associated with CRC risk. 
Adjusting for age, sex, smoking status and alcohol use. 
(35) 
Meta-analysis 3 prospective studies, 
3 retrospective studies. 
1 mix design 
PBL* PCR The current analysis is insufficient to provide evidence on the 
relationship between PBL telomere length and the risk of CRC. 
 
(36) 
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Colorectal Cancer Colon Cancer Rectal Cancer 






















2.042 (1.543, 2.701) 
2.628 (1.942, 3.556) 
3.754 (2.664, 5.289) 










2.319 (1.617, 3.326) 
3.124 (2.125, 4.593) 
4.252 (2.732, 6.626) 










1.697 (1.088 2.648) 
2.029 (1.242, 3.316) 
3.180 (1.848, 5.469) 

















































1.154 (0.782, 1.704) 
1.00 
1.010 (0.803, 1.295) 








0.973 (0.570, 1.659) 
1.00 
1.004 (0.739, 1.364) 








1.448 (0.817, 2.567) 
1.00 
1.044 (0.712, 1.530) 
1.026 (0.594, 1.771) 
0.5429 
Levels of education 
No formal education 
Primary (1-6 years) 












0.988 (0.744, 1.311) 








1.101 (0.763, 1.587) 








0.839 (0.536, 1.314) 

















1.153 (0.815, 1.633) 








0.995 (0.629, 1.573) 








1.442 (0.842, 2.468) 
1.425 (0.923, 2.200) 
0.1044 



















0.859 (0.522, 1.415) 
1.242 (0.911, 1.693) 









0.821 (0.435, 1.552) 
1.066 (0.708, 1.604) 









0.927 (0.415, 2.072) 
1.558 (0.963, 2.520) 
1.518 (0.930, 2.479) 
0.0423 
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1.163 (0.853, 1.584) 
1.110 (0.780, 1.580) 
1.039 (0.663, 1.629) 








1.064 (0.715, 1.582) 
0.867 (0.536, 1.404) 
0.706 (0.368, 1.355) 








1.344 (0.820, 2.202) 
1.555 (0.917, 2.639) 
1.647 (0.872, 3.111) 
1.166 (0.530, 2.565) 
0.1792 












1.045 (0.769, 1.420) 






1.071 (0.720, 1.591) 






1.009 (0.621, 1.640) 
1.185 (0.590, 2.379) 
0.7024 



















0.923 (0.646, 1.320) 
0.6404 








































1.784 (1.095, 2.905) 
0.0201 
*Adjusted for:  age, gender, BMI levels (<18.5, 18.5-<23.0, 23.0-<27.0, ≥27.0), education levels (no formal education, primary, secondary, and
above), smoking index (never smokers, light smokers, and heavy smokers), numbers of alcohol drinks per week (non-drinkers, <7 drinks/week,
and ≥7 drinks/week), weekly physical activity, family history of CRC, and diabetic status
.
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